Personalizing Precision Oncology Clinical Trials in Latin America: An Expert Panel on Challenges and Opportunities

The participation of patients in precision oncology trials needs to fulfill molecular‐based selection criteria. This strongly limits accrual, and as a consequence, screening successes have decreased, costs have increased, and fewer subjects are enrolled. To achieve narrowed targets, studies have bee...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Arai, Roberto Jun, Guindalini, Rodrigo Santa Cruz, Llera, Andrea Sabina, O'Connor, Juan Manoel, Muller, Bettina, Lema, Mauricio, Freitas, Helano C., Soria, Tannia, Delgado, Lucía, Landaverde, Denis, Montenegro, Paola, Riechelmann, Rachel P.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2019
Matèries:
Global Health and Cancer
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6693712/
https://ncbi.nlm.nih.gov/pubmed/30910864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0318
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars